Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

776

1

Candel Therapeutics, Inc. Candel Therapeutics Reports Significant Financial Challenges, Faces Doubt Over Ability to Continue as a Going Concern

Via official filing (AI summary) | 12 days ago | 0 comments

777

1

Biomotion Sciences Silexion Therapeutics Reports Significant Net Loss and Operating Expenses Increase in Nine Months Ended September 30, 2024

Via official filing (AI summary) | 12 days ago | 0 comments

778

1

Inhibikase Therapeutics, Inc. Inhibikase Therapeutics Reports Significant Financial Challenges, Raises $110M in Private Placement

Via official filing (AI summary) | 12 days ago | 0 comments

779

1

TANCHENG GROUP CO., LTD. Tancheng Group Reports Significant Declines in Financial Performance for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 12 days ago | 0 comments

780

1

Bitech Technologies Corp Bitech Technologies Reports Significant Financial Changes, Net Loss, and Shift to Green Energy Focus

Via official filing (AI summary) | 12 days ago | 0 comments

781

1

Mawson Infrastructure Group Inc. Mawson Infrastructure Group Reports Revenue Growth, Improved Profitability, and Strategic Developments in Q3 2024

Via official filing (AI summary) | 12 days ago | 0 comments

782

1

Zoned Properties, Inc. Zoned Properties Reports 43% Revenue Growth, Net Income Recovery in Q3 2024

Via official filing (AI summary) | 12 days ago | 0 comments

783

1

Rani Therapeutics Holdings, Inc. Rani Therapeutics Reports 33.9% Decrease in Operating Expenses, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | 12 days ago | 0 comments

784

1

Hyzon Motors Inc. Hyzon Motors Reports Decline in Financial Metrics, Revenue Growth Amid Restructuring Efforts

Via official filing (AI summary) | 12 days ago | 0 comments

785

1

Earth Science Tech, Inc. Earth Science Tech Reports Significant Revenue and Net Income Growth in Latest Quarter

Via official filing (AI summary) | 12 days ago | 0 comments

786

1

Sow Good Inc. Sow Good Inc. Reports Mixed Quarterly Results, But Sees Significant Growth in Revenues and Assets

Via official filing (AI summary) | 12 days ago | 0 comments

787

1

CURIS INC Curis, Inc. Reports Revenue Growth, Net Loss, and Cash Decline in Q3 2024

Via official filing (AI summary) | 12 days ago | 0 comments

788

1

iQSTEL Inc iQSTEL Inc. Reports Significant Revenue Growth, Widening Losses in Q3 2024

Via official filing (AI summary) | 12 days ago | 0 comments

789

1

Sensei Biotherapeutics, Inc. Sensei Biotherapeutics Reports Q3 Financial Results, Announces Restructuring Plan

Via official filing (AI summary) | 12 days ago | 0 comments

790

1

Sagimet Biosciences Inc. Sagimet Biosciences Reports Increased Assets, Wider Losses in Latest Quarter

Via official filing (AI summary) | 12 days ago | 0 comments

791

1

Talen Energy Corp Talen Energy Reports Significant Financial Improvements in Q3 and Nine-Month Periods

Via official filing (AI summary) | 12 days ago | 0 comments

792

1

Nuvera Communications, Inc. Nuvera Communications Reports Mixed Q3 Results, Revenue Growth Offset by Decline in Net Income

Via official filing (AI summary) | 12 days ago | 0 comments

793

1

ZyVersa Therapeutics, Inc. ZyVersa Therapeutics Reports Significant Financial Challenges, Decreased Cash Position, and Ongoing Operating Losses in Latest 10-Q Filing

Via official filing (AI summary) | 12 days ago | 0 comments

794

1

Odysight.ai Inc. Odysight.ai Reports 145% Revenue Growth, Net Loss in 9-Month Period Ending September 30, 2024

Via official filing (AI summary) | 12 days ago | 0 comments

795

1

Guerrilla RF, Inc. Guerrilla RF Reports 52% Revenue Growth, Improved Cash Position, and Restructured Debt for Nine Months Ended September 30, 2024

Via official filing (AI summary) | 12 days ago | 0 comments

796

1

GALECTIN THERAPEUTICS INC Galectin Therapeutics Reports Third Quarter Loss, Cash and Cash Equivalents Increase

Via official filing (AI summary) | 12 days ago | 0 comments

797

1

Leet Technology Inc. Leet Technology Reports Significant Revenue Growth and Net Profit in Q3 2024

Via official filing (AI summary) | 12 days ago | 0 comments

798

1

Livento Group, Inc. Livento Group Reports Decline in Revenue and Net Loss for Q3 2024

Via official filing (AI summary) | 12 days ago | 0 comments

799

1

Iterum Therapeutics plc Iterum Therapeutics Reports Financial Developments, Raises Capital, and Faces Challenges

Via official filing (AI summary) | 12 days ago | 0 comments

800

1

FITLIFE BRANDS, INC. FitLife Brands Reports 15% Revenue Growth, 81% Net Income Increase in Q3 2024

Via official filing (AI summary) | 12 days ago | 0 comments